At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback